LAOCAINE
LAOCAINE
Authorised
- Lidocaine hydrochloride monohydrate
Product identification
Medicine name:
LAOCAINE
Active substance:
- Lidocaine hydrochloride monohydrate
Target species:
-
Dog
-
Cat
-
Equid
Route of administration:
-
Epidural use
-
Subcutaneous use
Product details
Active substance and strength:
-
Lidocaine hydrochloride monohydrate20.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Epidural use
-
Dog
-
Cat
-
Equid
-
Meat and offal3day
-
Milk3day
-
-
-
Subcutaneous use
-
Dog
-
Cat
-
Equid
-
Meat and offal3day
-
Milk3day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN01BB02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Intervet
Marketing authorisation date:
Manufacturing sites for batch release:
- Trirx Segre
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/1327125 5/1980
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
